Access Expansion Heading Health focuses on affordable, high-quality mental health care delivered via teletherapy and telepsychiatry, presenting a sales opportunity to partner with payers, employers, and healthcare networks seeking scalable, virtual treatment options for treatment-resistant depression, anxiety, and PTSD.

Hybrid Care Model The integration of interventional treatments such as Spravato, transcranial magnetic stimulation, and intramuscular ketamine creates a differentiated offering that can be bundled into employer health plans or clinic partnerships targeting patients who require advanced modalities beyond standard therapy.

Funding Backing Past and current investors, including SeedtoB Capital and $4.5M Series A financiers, signal credibility and growth momentum, making Heading Health appealing for strategic alliances, co-development, and accelerated channel partnerships with digital health platforms and insurers.

Growth Channels Active use of digital channels and platforms (Braze, Google tools, Zocdoc, YouTube) indicates readiness for targeted patient acquisition and employer outreach campaigns; sales opportunities exist in partnering with benefit administrators and HR teams to expand coverage and access.

Geographic & Market Fit Based in Austin with recent global event participation, Heading Health seeks broader access and international exposure; opportunities exist to collaborate with retailers, multinational employers, and telehealth networks aiming to scale mental health services across diverse markets.